DESENSITIZATION TO RIVAROXABAN IN A PATIENT WHO EXPERIENCED ANAPHYLACTOID SHOCK AFTER ANTICOAGULANT USE: CASE REPORT

Case Report: Over the last two decades, new anticoagulants have been developed to prevent and manage thromboembolic diseases, including direct-acting anticoagulants like rivaroxaban, which is used for venous thromboembolism prevention, stroke prevention in atrial fibrillation, and ischemic heart dis...

Full description

Bibliographic Details

Published in:	Hematology, Transfusion and Cell Therapy
Main Authors:	Damla Cagla Patır, Nigar Abdullayeva, Züleyha Galata, Umitcan Ates, Kutay Kırdok, Tugba Mermer, Sükriye Miray Bozgul, Reyhan Gumusburun, Elif Ertuna, Aytül Zerrin Sin, Mahmut Tobu
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137924028864